Compliance considerations in relation to the misuse of drugs in the medical marijuana market
Collas Crill group partner Wayne Atkinson will be speaking on Thursday 11 July, at the BPP CI 2019 Guernsey Risk & Compliance CPD Seminar Series on compliance considerations in relation to the misuse of drugs in the medical marijuana market.
Wayne works as one of the leaders of Collas Crill's risk and regulatory team, regularly advising businesses on regulatory compliance including money-laundering issues, listing rules requirements, competition law, data protection and Guernsey financial services regulation more generally.
This seminar forms part of the 2019 Guernsey Risk & Compliance CPD Seminar Series. It brings together all financial services professionals, in specific those working within the compliance function.
For more information on this conference please click here.
